207 related articles for article (PubMed ID: 34471236)
1. SRT1720 inhibits the growth of bladder cancer in organoids and murine models through the SIRT1-HIF axis.
Tan P; Wang M; Zhong A; Wang Y; Du J; Wang J; Qi L; Bi Z; Zhang P; Lin T; Zhang J; Yang L; Chen J; Han P; Gong Q; Liu Y; Chen C; Wei Q
Oncogene; 2021 Oct; 40(42):6081-6092. PubMed ID: 34471236
[TBL] [Abstract][Full Text] [Related]
2. SRT1720 induces lysosomal-dependent cell death of breast cancer cells.
Lahusen TJ; Deng CX
Mol Cancer Ther; 2015 Jan; 14(1):183-92. PubMed ID: 25411356
[TBL] [Abstract][Full Text] [Related]
3. Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin-induced mouse model of asthma.
Ichikawa T; Hayashi R; Suzuki K; Imanishi S; Kambara K; Okazawa S; Inomata M; Yamada T; Yamazaki Y; Koshimizu Y; Miwa T; Matsui S; Usui I; Urakaze M; Matsuya Y; Sasahara M; Tobe K
Respirology; 2013 Feb; 18(2):332-9. PubMed ID: 23062010
[TBL] [Abstract][Full Text] [Related]
4. SRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in mice.
Suzuki K; Hayashi R; Ichikawa T; Imanishi S; Yamada T; Inomata M; Miwa T; Matsui S; Usui I; Urakaze M; Matsuya Y; Ogawa H; Sakurai H; Saiki I; Tobe K
Oncol Rep; 2012 Jun; 27(6):1726-32. PubMed ID: 22470132
[TBL] [Abstract][Full Text] [Related]
5. SRT1720 induces SIRT1-independent cell death in adult T-cell leukemia/lymphoma.
Kozako T; Kato N; Ohsugi T; Uchida YI; Yoshimitsu M; Ishitsuka K; Higaki Y; Sato H; Aikawa A; Honda SI
FEBS J; 2022 Jun; 289(12):3477-3488. PubMed ID: 35029032
[TBL] [Abstract][Full Text] [Related]
6. The Sirt1 activator, SRT1720, attenuates renal fibrosis by inhibiting CTGF and oxidative stress.
Ren Y; Du C; Shi Y; Wei J; Wu H; Cui H
Int J Mol Med; 2017 May; 39(5):1317-1324. PubMed ID: 28339034
[TBL] [Abstract][Full Text] [Related]
7. SRT1720 inhibits bladder cancer cell progression by impairing autophagic flux.
Li L; Fu S; Wang J; Lu J; Tao Y; Zhao L; Fu B; Lu L; Xiang C; Sun X; Liu S; Wang D; Wang Z
Biochem Pharmacol; 2024 Apr; 222():116111. PubMed ID: 38458329
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of SRT1720 on the apoptosis of rabbit chondrocytes by activating SIRT1 via p53/bax and NF-κB/PGC-1α pathways.
Liu B; Lei M; Hu T; Yu F; Xiao DM; Kang H
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):350-355. PubMed ID: 27376802
[TBL] [Abstract][Full Text] [Related]
9. Specific Sirt1 Activator-mediated Improvement in Glucose Homeostasis Requires Sirt1-Independent Activation of AMPK.
Park SJ; Ahmad F; Um JH; Brown AL; Xu X; Kang H; Ke H; Feng X; Ryall J; Philp A; Schenk S; Kim MK; Sartorelli V; Chung JH
EBioMedicine; 2017 Apr; 18():128-138. PubMed ID: 28396013
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor 1 alpha promotes cancer stem cells-like properties in human ovarian cancer cells by upregulating SIRT1 expression.
Qin J; Liu Y; Lu Y; Liu M; Li M; Li J; Wu L
Sci Rep; 2017 Sep; 7(1):10592. PubMed ID: 28878214
[TBL] [Abstract][Full Text] [Related]
11. The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction, excessive superoxide production, and inflammation with aging in mice.
Gano LB; Donato AJ; Pasha HM; Hearon CM; Sindler AL; Seals DR
Am J Physiol Heart Circ Physiol; 2014 Dec; 307(12):H1754-63. PubMed ID: 25326534
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture.
Elbadawy M; Usui T; Mori T; Tsunedomi R; Hazama S; Nabeta R; Uchide T; Fukushima R; Yoshida T; Shibutani M; Tanaka T; Masuda S; Okada R; Ichikawa R; Omatsu T; Mizutani T; Katayama Y; Noguchi S; Iwai S; Nakagawa T; Shinohara Y; Kaneda M; Yamawaki H; Sasaki K
Cancer Sci; 2019 Sep; 110(9):2806-2821. PubMed ID: 31254429
[TBL] [Abstract][Full Text] [Related]
13. SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF‑κB pathway in mouse kupffer cells.
Niu B; He K; Li P; Gong J; Zhu X; Ye S; Ou Z; Ren G
Mol Med Rep; 2018 Aug; 18(2):1609-1615. PubMed ID: 29845302
[TBL] [Abstract][Full Text] [Related]
14. Differential roles of Sirt1 in HIF-1α and HIF-2α mediated hypoxic responses.
Yoon H; Shin SH; Shin DH; Chun YS; Park JW
Biochem Biophys Res Commun; 2014 Jan; 444(1):36-43. PubMed ID: 24423936
[TBL] [Abstract][Full Text] [Related]
15. HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4.
Yu M; Ozaki T; Sun D; Xing H; Wei B; An J; Yang J; Gao Y; Liu S; Kong C; Zhu Y
J Exp Clin Cancer Res; 2020 Jun; 39(1):108. PubMed ID: 32522234
[TBL] [Abstract][Full Text] [Related]
16. An Agonist of the Protective Factor SIRT1 Improves Functional Recovery and Promotes Neuronal Survival by Attenuating Inflammation after Spinal Cord Injury.
Chen H; Ji H; Zhang M; Liu Z; Lao L; Deng C; Chen J; Zhong G
J Neurosci; 2017 Mar; 37(11):2916-2930. PubMed ID: 28193684
[TBL] [Abstract][Full Text] [Related]
17. SIRT1 activator (SRT1720) improves the follicle reserve and prolongs the ovarian lifespan of diet-induced obesity in female mice via activating SIRT1 and suppressing mTOR signaling.
Zhou XL; Xu JJ; Ni YH; Chen XC; Zhang HX; Zhang XM; Liu WJ; Luo LL; Fu YC
J Ovarian Res; 2014 Oct; 7():97. PubMed ID: 25330910
[TBL] [Abstract][Full Text] [Related]
18. Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2/3 transactivation.
Bugyei-Twum A; Ford C; Civitarese R; Seegobin J; Advani SL; Desjardins JF; Kabir G; Zhang Y; Mitchell M; Switzer J; Thai K; Shen V; Abadeh A; Singh KK; Billia F; Advani A; Gilbert RE; Connelly KA
Cardiovasc Res; 2018 Oct; 114(12):1629-1641. PubMed ID: 29800064
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells.
Chauhan D; Bandi M; Singh AV; Ray A; Raje N; Richardson P; Anderson KC
Br J Haematol; 2011 Dec; 155(5):588-98. PubMed ID: 21950728
[TBL] [Abstract][Full Text] [Related]
20. The beneficial role of SIRT1 activator on chemo- and radiosensitization of breast cancer cells in response to IL-6.
Masoumi H; Soltani A; Ghatrehsamani M
Mol Biol Rep; 2020 Jan; 47(1):129-139. PubMed ID: 31781916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
